Xiaolei Wei

488 total citations
38 papers, 341 citations indexed

About

Xiaolei Wei is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, Xiaolei Wei has authored 38 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pathology and Forensic Medicine, 14 papers in Oncology and 9 papers in Immunology. Recurrent topics in Xiaolei Wei's work include Lymphoma Diagnosis and Treatment (19 papers), Viral-associated cancers and disorders (8 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Xiaolei Wei is often cited by papers focused on Lymphoma Diagnosis and Treatment (19 papers), Viral-associated cancers and disorders (8 papers) and CNS Lymphoma Diagnosis and Treatment (5 papers). Xiaolei Wei collaborates with scholars based in China, United States and Canada. Xiaolei Wei's co-authors include Zhiqiang Ge, Yongqiang Wei, Ru Feng, Xiaoxiao Hao, Fen Huang, Wei Qi, Hui Jing, Lizhi Zhou, Hong Zeng and Weimin Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Xiaolei Wei

31 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaolei Wei China 10 148 127 69 51 48 38 341
Dave Johnson United States 8 69 0.5× 90 0.7× 97 1.4× 35 0.7× 32 0.7× 11 274
Weibo Xia China 12 102 0.7× 59 0.5× 69 1.0× 52 1.0× 46 1.0× 41 390
Haocheng Li Canada 12 125 0.8× 14 0.1× 74 1.1× 32 0.6× 30 0.6× 29 393
Anna Kron Germany 12 90 0.6× 31 0.2× 54 0.8× 29 0.6× 33 0.7× 43 403
Orsolya Lautner‐Csorba United States 11 89 0.6× 29 0.2× 67 1.0× 48 0.9× 11 0.2× 18 333
Gurpreet Lamba United States 8 113 0.8× 64 0.5× 107 1.6× 65 1.3× 19 0.4× 22 464
Guillermo De Angulo United States 7 96 0.6× 32 0.3× 92 1.3× 97 1.9× 127 2.6× 10 427
Yang Lv China 10 52 0.4× 48 0.4× 99 1.4× 13 0.3× 51 1.1× 19 335
Stayce E. Beck United States 15 133 0.9× 106 0.8× 286 4.1× 78 1.5× 14 0.3× 25 709
Sara M. Radwan Egypt 11 55 0.4× 24 0.2× 72 1.0× 37 0.7× 24 0.5× 27 262

Countries citing papers authored by Xiaolei Wei

Since Specialization
Citations

This map shows the geographic impact of Xiaolei Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolei Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolei Wei more than expected).

Fields of papers citing papers by Xiaolei Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolei Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolei Wei. The network helps show where Xiaolei Wei may publish in the future.

Co-authorship network of co-authors of Xiaolei Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolei Wei. A scholar is included among the top collaborators of Xiaolei Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolei Wei. Xiaolei Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Tang, Wenting, Wei Lin, Ling Jiang, et al.. (2025). Enhancing plasmacytoid dendritic cell functionality with all-trans retinoic acid for improved multiple myeloma therapy. PubMed. 33(2). 200992–200992.
4.
5.
6.
Wei, Xiaolei, Yue Zhu, Xianfeng Zha, et al.. (2024). Single‐Cell Multiomics Reveals TCR Clonotype‐Specific Phenotype and Stemness Heterogeneity of T‐ALL Cells. Cell Proliferation. 58(4). e13786–e13786. 1 indexed citations
7.
Wei, Xiaolei & Yongqiang Wei. (2023). Stem cell mobilization in multiple myeloma: challenges, strategies, and current developments. Annals of Hematology. 102(5). 995–1009. 6 indexed citations
8.
Zhang, Yunxia, et al.. (2023). Curcumin Enhances Ibrutinib Induced Killing Effect Against TP53-Mutated Chronic Lymphocytic Leukemia Cells in Vitro. Blood. 142(Supplement 1). 5792–5792. 1 indexed citations
9.
Wei, Xiaolei, Zewen Zhang, Weimin Huang, et al.. (2021). Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma. Frontiers in Oncology. 10. 610681–610681. 13 indexed citations
10.
Zhang, Yuping, Xiaolei Wei, Zhi Yu, et al.. (2020). CD8+GITR+ T cells may negatively regulate T cell overactivation in aplastic anemia. Immunological Investigations. 50(4). 406–415. 6 indexed citations
11.
Wei, Yongqiang, Xiaolei Wei, Weimin Huang, et al.. (2020). Albumin improves stratification in the low IPI risk patients with diffuse large B-cell lymphoma. International Journal of Hematology. 111(5). 681–685. 9 indexed citations
12.
Chung, Elaine Y., Urvi A. Shah, Yongqiang Wei, et al.. (2019). PAK Kinase Inhibition Has Therapeutic Activity in Novel Preclinical Models of Adult T-Cell Leukemia/Lymphoma. Clinical Cancer Research. 25(12). 3589–3601. 17 indexed citations
13.
Huang, Weimin, Xiaolei Wei, Yongqiang Wei, & Ru Feng. (2018). Biology of Tumor Associated Macrophages in Diffuse Large B Cell Lymphoma. DNA and Cell Biology. 37(12). 947–952. 2 indexed citations
14.
Wei, Xiaolei, Xiaoxiao Hao, Lizhi Zhou, et al.. (2017). The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP. Scientific Reports. 7(1). 13592–13592. 4 indexed citations
15.
Hao, Xiaoxiao, Yongqiang Wei, Xiaolei Wei, et al.. (2017). Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma. Oncotarget. 8(44). 76740–76748. 33 indexed citations
16.
Wei, Yongqiang, Fen Huang, Xiaolei Wei, et al.. (2016). Low prognostic nutritional index predicts poor outcome in diffuse large B-cell lymphoma treated with R-CHOP. International Journal of Hematology. 104(4). 485–490. 32 indexed citations
17.
Hao, Xiaoxiao, Xiaolei Wei, Fen Huang, et al.. (2015). The Expression of CD30 Based on Immunohistochemistry Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma. PLoS ONE. 10(5). e0126615–e0126615. 18 indexed citations
18.
Wei, Xiaolei, Yongqiang Wei, Fen Huang, et al.. (2014). Lymphopenia predicts preclinical relapse in the routine follow-up of patients with diffuse large B-cell lymphoma. Leukemia & lymphoma. 56(5). 1261–1265. 5 indexed citations
19.
Wei, Xiaolei, Meng Xu, Yongqiang Wei, et al.. (2014). The addition of rituximab to CHOP therapy alters the prognostic significance of CD44 expression. Journal of Hematology & Oncology. 7(1). 34–34. 14 indexed citations
20.
Wei, Xiaolei, Fen Huang, Yongqiang Wei, et al.. (2014). Low lymphocyte-to-monocyte ratio predicts unfavorable prognosis in non-germinal center type diffuse large B-cell lymphoma. Leukemia Research. 38(6). 694–698. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dave Johnson Breakdown of academic impact, for papers by Weibo Xia Breakdown of academic impact, for papers by Haocheng Li Breakdown of academic impact, for papers by Anna Kron Breakdown of academic impact, for papers by Orsolya Lautner‐Csorba Breakdown of academic impact, for papers by Gurpreet Lamba Breakdown of academic impact, for papers by Guillermo De Angulo Breakdown of academic impact, for papers by Yang Lv Breakdown of academic impact, for papers by Stayce E. Beck Breakdown of academic impact, for papers by Sara M. Radwan
Rankless by CCL
2026